beyond glp-1 The cardiovascular effects of receptor agonists obesity and type 2 diabetes: An anti-atherosclerotic action Your Built-in GLP-1, No Prescription

PMC Xie X, et al

Dude looks like he was just thawed from an ice block, one commented online Image credits: Logan9617835242 Image credits: TurntUpDylan Image credits: eth_taco Image credits: PiusGoodne67858 Image credits: DTWFreak Image credits: Luk4Den Image credits: ryankramerllc Image credits: clevebarb Image credits: 123yourfren Image credits: 0xSweep Image credits: SleepySimulacra

Figure 2 Within the SOC level, gastrointestinal system disorders in overall GLP-1 RAs were overreported compared with the background frequency (ROR 1.46, PRR 1.33, IC 0.41, EBGM 1.33), which were further attributed to liraglutide (ROR 2.39, PRR 1.84, IC 0.88, EBGM 1.33), dulaglutide (ROR 1.39, PRR 1.28, IC 0.36, EBGM 1.25), and semaglutide (ROR 3.00, PRR 2.10, IC 1.07, EBGM 2.10), while exenatide (ROR 0.57, PRR 0.63, IC 0.68, EBGM 0.63) and lixisenatide (ROR 0.51, PRR 0.57, IC 0.81, EBGM 0.57) did not show the association with gastrointestinal AEs ( Table 2 )

If you have feelings of hopelessness, guilt, numbness, grief, and loneliness, theres a chance youre suffering from depression

Every patient goes through a real medical evaluation before any prescription is written